| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$130,490 ) |
| | 2025 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR STE 300 | MORRISVILLE | NC | 27560-7101 | WAKE | USA | R41TR004324 | Microfluidic technology platform as a continuous end-line process to inactivate pharmaceuticals | 000 | 1 | NIH | 10/8/2024 | -$130,490 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR STE 300 | MORRISVILLE | NC | 27560-7101 | WAKE | USA | R41CA285172 | An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors | 000 | 1 | NIH | 3/11/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $973,170 ) |
| | 2023 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR STE 300 | MORRISVILLE | NC | 27560-7101 | WAKE | USA | R43AI177140 | A next generation cross-serotype binding antitoxin for treatment of post-exposure botulinum poisoning | 000 | 1 | NIH | 8/30/2023 | $299,411 |
| | 2023 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR | MORRISVILLE | NC | 27560-6847 | WAKE | USA | R41TR004324 | Microfluidic technology platform as a continuous end-line process to inactivate pharmaceuticals | 001 | 1 | NIH | 4/5/2023 | $0 |
| | 2023 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR | MORRISVILLE | NC | 27560-6847 | WAKE | USA | R41TR004324 | Microfluidic technology platform as a continuous end-line process to inactivate pharmaceuticals | 000 | 1 | NIH | 12/9/2022 | $274,649 |
| | 2023 | 2023 | NIGHTHAWK BIOSCIENCES, INC. | 627 DAVIS DR STE 300 | MORRISVILLE | NC | 27560-7101 | WAKE | USA | R41CA285172 | An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors | 000 | 1 | NIH | 9/19/2023 | $399,110 |
|
| Issue Date FY: 2010 ( Subtotal = $300,000 ) |
| | 2010 | 2010 | HEAT BIOLOGICS INC | 119 WASHINGTON AVENUE | MIAMI BEACH | FL | 33139 | MIAMI-DADE | USA | R43AI085929 | DEVELOPMENT OF ANTI-HUMAN TL1A MONOCLONAL ANTIBODY FOR THE TREATMENT OF HUMAN AST | 000 | 1 | NIH | 4/6/2010 | $300,000 |
|
|
